A study to evaluate the duration of omeprazole treatment for gastric artificial ulcer after ESD

A study to evaluate the duration of omeprazole treatment for gastric artificial ulcer after ESD - A study to evaluate the duration of omeprazole treatment for gastric artificial ulcer after ESD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005750

Enrollment

Registered

2011-06-13

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent ESD for the treatment of gastorointestinal stromal tumor (no less than 20 years old)

Interventions

Omeprazole

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent ESD for the treatment of gastorointestinal stromal tumor

Exclusion criteria

Exclusion criteria: 1) Patients with previous partial gastrectomy or vagotomy 2) Patients receiving anti-coagulants, anti-platelet agents, or steroids 3) Patients with sever cerebral, cardiac, renal, or hematopoietic dysfunction 4) Patients with hypersensitivity to omeprazole 5) Pregnant or lactating women or women who plan to become pregnant during the study 6) Patients who underwent H. pylori eradication after ESD

Design outcomes

Primary

Measure	Time frame
tumor volume, tumor stage, gastrointestinal questionnaire, GRSR score	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026